Invention Application
US20150344481A1 NOVEL SUBSTITUTED IMIDAZOLES AS CASEIN KINASE 1 D/E INHIBITORS
有权
新西兰替米沙坦作为CASEIN KINASE 1 D / E抑制剂
- Patent Title: NOVEL SUBSTITUTED IMIDAZOLES AS CASEIN KINASE 1 D/E INHIBITORS
- Patent Title (中): 新西兰替米沙坦作为CASEIN KINASE 1 D / E抑制剂
-
Application No.: US14653895Application Date: 2013-12-20
-
Publication No.: US20150344481A1Publication Date: 2015-12-03
- Inventor: Upender Velaparthi , Chetan Padmakar Darne , Dharmpal S. Dodd , Anthony J. Sampognaro , Mark D. Wittman , Selvakumar Kumaravel , Dibakar Mullick , Peiying Liu , Chandrasekhar Reddy Rachamreddy
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- International Application: PCT/US2013/076795 WO 20131220
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D519/00
Abstract:
The invention provides compounds of Formula (I) and pharmaceutically acceptable salts thereof. The compounds of Formula (I) inhibit protein kinase activity thereby making them useful as anticancer agents.
Public/Granted literature
- US09556179B2 Substituted imidazoles as casein kinase 1 D/E inhibitors Public/Granted day:2017-01-31
Information query
